High phenylacetic acid differentiates schizoaffective from schizophrenic patients

Area of Science:

• Biochemistry
• Neuroscience
• Psychiatry

Background:

• Schizoaffective disorder and schizophrenia are distinct psychiatric conditions.
• Understanding biochemical differences may aid in diagnosis and treatment.
• Phenylalanine metabolism is crucial for neurotransmitter synthesis.

Purpose of the Study:

• To investigate biochemical differences between acutely psychotic schizoaffective and schizophrenic patients.
• To explore potential alterations in phenylalanine metabolism in these conditions.

Main Methods:

• Collected 24-hour urine samples from patients.
• Measured urinary phenylacetic acid levels.
• Compared levels between schizoaffective and schizophrenic patient groups.

Main Results:

• Urinary phenylacetic acid was significantly high in acutely psychotic schizoaffective patients (240.3 +/- 51.9 mg/day).
• Urinary phenylacetic acid was significantly low in acutely psychotic schizophrenic patients (53.6 +/- 15.1 mg/day).

Conclusions:

• Acutely psychotic schizoaffective and schizophrenic patients exhibit distinct urinary phenylacetic acid levels.
• These findings suggest underlying biochemical differences, specifically in phenylalanine metabolism, between the two diagnoses.